-
21
Dual-targeting CAR T cells for B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
22
Measurable residual disease as predictor of post–day +100 relapses after allografting in adult AML
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
23
Long-term real-world evidence of CPX-351 of high-risk patients with AML identified high rate of negative MRD and prolonged OS
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
24
A telemedicine triage model for infusion center–based management of adult sickle cell pain episodes
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
25
-
26
Congenital T-cell activation impairs transitional-to-follicular B-cell maturation in humans
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
27
Venetoclax plus low-intensity chemotherapy for adults with acute lymphoblastic leukemia
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
28
Impact of prior CAR T-cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
29
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
30
The E3 ubiquitin ligase MARCH5 promotes mitochondrial fusion and cell-cycle progression in acute myeloid leukemia
Published 2025-01-01“…Blood Advances…”
Get full text
Article -
31
Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
32
MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
33
The roadmap to integrate diversity, equity, and inclusion in hematology clinical trials: an American Society of Hematology initiative
Published 2025-02-01“…Blood Advances…”
Get full text
Article